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Abstract
Objectives In breast cancer screening, two readers separately examine each woman’s mammograms for signs of cancer. We
examined whether preventing the two readers from seeing each other’s decisions (blinding) affects behaviour and outcomes.
Methods This cohort study used data from the CO-OPS breast-screening trial (1,119,191 women from 43 screening centres in
England) where all discrepant readings were arbitrated. Multilevel models were fitted using Markov chain Monte Carlo to measure
whether reader 2 conformed to the decisions of reader 1when theywere not blinded, and the effect of blinding on overall rates of recall
for further tests and cancer detection. Differences in positive predictive value (PPV) were assessed using Pearson’s chi-squared test.
Results When reader 1 recalls, the probability of reader 2 also recalling was higher when not blinded than when blinded,
suggesting readers may be influenced by the other’s decision. Overall, women were less likely to be recalled when reader 2
was blinded (OR 0.923; 95% credible interval 0.864, 0.986), with no clear pattern in cancer detection rate (OR 1.029; 95%
credible interval 0.970, 1.089; Bayesian p value 0.832). PPV was 22.1% for blinded versus 20.6% for not blinded (p < 0.001).
Conclusions Our results suggest that when not blinded, reader 2 is influenced by reader 1’s decisions to recall (alliterative bias)
which would result in bypassing arbitration and negate some of the benefits of double-reading. We found a relationship between
blinding the second reader and slightly higher PPV of breast cancer screening, although this analysis may be confounded by other
centre characteristics.
Key Points
• In Europe, it is recommended that breast screening mammograms are analysed by two readers but there is little evidence on the
effect of ‘blinding’ the readers so they cannot see each other’s decisions.
•We found evidence that when the second reader is not blinded, they are more likely to agree with a recall decision from the first
reader and less likely to make an independent judgement (alliterative error). This may reduce overall accuracy through
bypassing arbitration.
• This observational study suggests an association between blinding the second reader and higher positive predictive value of
screening, but this may be confounded by centre characteristics.
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Breast cancer screening is implemented in many European
countries. European quality assurance guidelines recommend
that mammograms are examined for signs of cancer by two
radiologists (readers) using two mammographic views [1, 2].
There is evidence that this approach increases the cancer de-
tection rate compared to single reading [3–7]. A retrospective
analysis of women participating in the English NHS Breast
Screening Programme identified that double reading with ar-
bitration of discordant decisions reduced recall and increased
cancer detection rates, compared to hypothetical single read-
ing [7]. However, the cancers detected only by the second
reader were smaller, had fewer involved nodes, and were of
lower grade [7]. This finding is consistent with some prior
research [8]. The identification of smaller lower grade cancers
and DCIS may be beneficial, or it may not be a desirable
outcome of breast cancer screening due to their association
with overdiagnosis [9]. There is therefore currently debate
about the efficacy of double reading [10].
An aspect of double reading that has received little research
to date is the blinding of reader 2 to the decisions of reader 1.
Previous European guidance has recommended blinding, but
the most recent version omits any recommendation on
blinding except for in research studies [1, 2]. There is some
evidence that blinding may affect diagnostic accuracy and
patient outcomes. One study investigated a consecutive series
of mammograms from women participating in the national
Dutch screening programme, with no arbitration of discordant
results. This study found that blinded double reading resulted
in higher programme sensitivity than non-blinded reading
(83% vs 76%, p = 0.01) [11], albeit with higher benign biopsy
rates when blinded (2.6 vs 1.4 per 1000 screens p < 0.001 for
ultrasound-guided core needle biopsy (CNB), and 5.9 vs 4.7
per 1000 screens p = 0.013 for stereotactic CNB) [12]. These
results suggest that reader 2 might be influenced by reader 1’s
decisions, but are not applicable to screening programmes
which use arbitration of discordant reader decisions. The same
study team produced some projections of the effect of blinding
in this context, using a retrospective laboratory rather than
clinical practice arbitration decision [13, 14].
In his monograph on errors in radiology, Smith [15] intro-
duced the term ‘alliterative error’ to describe the influence that
one radiologist can have on another. He suggested that, for ex-
ample, if during an initial interpretation of a radiographic image
an abnormality is missed, or a benign finding overemphasised,
subsequent interpretations may lead to the same erroneous con-
clusion. This can occur when the subsequent interpretation of the
original image is carried out by a different reader or the original
reader. Smith proposed that this may occur because the second
reader reads the results of previous examinations before making
their own decision, and then tend to adopt the same position,
conforming to the belief of their peers. While there have been
few published studies of alliterative errors, it is often reported as
a source of error in radiology [16–19].
If non-blinded decision-making can introduce alliterative
bias, this could affect rates of recall, cancer detection, and
outcomes for women attending screening. Optimising reading
conditions could improve the balance of benefits and harms of
breast screening. The aim of this research was to determine the
effect of blinding the second reader in breast cancer screening
on alliterative error and subsequently the effect on screening
accuracy (recall and cancer detection rate), in a population




This study is reported using the ‘STROBE’ statement [20].
The study is a population-based cohort study within the
Changing Case Order to Optimise Patterns of Performance
in Screening (CO-OPS) trial. The original trial investigated
patterns of performance and fatigue with time on task, and is
described in detail elsewhere [21]. Briefly, the trial included
1,194,147 women (predominantly aged 47–73 years) attend-
ing routine triennial digital mammography screening between
December 2012 and November 2014 at 46 English centres.
Women with high-familial risk and who presented symptom-
atically were excluded. Digital mammograms were assessed
independently by two expert readers (radiologists, radiogra-
phy advanced practitioners, breast clinicians) for signs of can-
cer and whether a woman should be recalled for further inves-
tigation. Readers in the screening programme are required to
examine a minimum of 5000 mammograms a year and have
undergone extensive training [22]. Arbitration was used at all
centres when there were disagreements between the two
readers (13 centres used a third reader, 33 used group consen-
sus of 2 or more readers). Additionally, at some centres, arbi-
tration was used even when both readers suggested recall, in
an effort to reduce overall recall rates. The National Breast
Screening Service (NBSS) database records the decisions of
the readers and clinical information for each woman.
Data collection
Data were extracted from the NBSS system. Fields which
indicate the ‘blind’ status at the time reader 1 and reader 2
saved their opinions were extracted. Reader 1 selects whether
reading is blinded and then the second reader can change this
during their reading session. When the blind reporting option
is selected in NBSS, it masks the opinions of the previous
reader by showing ‘Entered’ in place of the opinions. In the
blinded reading condition, reader 2 could still ascertain what
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reader 1 decided by looking through the paper notes; however,
this would be rare due to time constraints in the high-volume
screening environment.
Statistical analysis
Summary statistics of the characteristics of the women
screened and the outcomes by the first reader, second reader
and after arbitration of discordant decisions were presented by
whether reader 2 was blinded. To investigate whether alliter-
ative bias was present, we compared the proportion of cases
where there were discordant decisions between readers using a
chi-squared test. The hypothesis was that blinding the second
reader would increase disagreements by reducing alliterative
bias. We then directly modelled whether the second reader
was influenced by the first reader’s decision when not blinded,
i.e. whether alliterative bias was present. The model outcome
was the second reader decision, with fixed effects for whether
reader 1 recalled the woman and whether reader 2 was
blinded, and an interaction term between them.
We fitted a multi-level model using Markov chain Monte
Carlo (MCMC) methods using R2MLwiN [23], which runs
the multilevel modelling programMLwiN [24, 25] fromwith-
in the ‘R’ environment. A MCMC approach provides several
advantages over maximum likelihood estimation in this con-
text. It can achieve more accurate model estimates particularly
with more complex models and gives a posterior probability
distribution for the parameters, rather than a p value [26–28].
The unit of analysis was the woman screened, with clustering
by reader and centre. We included fixed effects for whether a
woman was attending her first or a subsequent screen and the
woman’s age (continuous, centred). Random effects were in-
cluded for the second reader (level 2) and screening centre
(level 3).
To investigate whether any alliterative bias may affect
screening accuracy, we modelled whether blinding the second
reader was associated with differences in overall recall and
cancer detection rates. Two interaction terms were considered
for inclusion, based on the Bayesian deviance information
criterion (DIC) to assess overall model fit and the p value of
the z-score for an estimate (5% level) [23]. An interaction
between blinding and age was included because younger
women tend to have a higher density of breast tissue, increas-
ing task difficulty [29]. An interaction between blinding and
previous screening attendance was assessed because a lack of
previous mammograms for comparison also increases task
difficulty. Cancer detection and recall rate for reader 2 (with-
out arbitration) were also modelled to assess the intervention
effect (Supplementary Material Appendix A).
Tumour characteristics (DCIS grade, disease grade, inva-
sive disease presence, number of positive axillary nodes, max-
imum diameter of invasive disease) were determined for
blinded/non-blinded reader 2 with statistical testing (χ2 test
for independence, test for equality of two proportions and t
test) to determine any significant differences. The positive
predictive value (PPV) when blinding the second reader com-
pared to not blinding was reported, using the reference stan-
dard of biopsy-proven cancer after recall from screening.
Pearson’s chi-squared test was used to compare PPV in cases
read blinded and not blinded. To assess the potential impact of
centre confounding (fully blinded centre, vs fully non-blinded,
vs mixed centres), all the above models were run with a subset
of six centres which had a mix of blinded and non-blinded
reading as a sensitivity analysis. A mixed protocol centre was
one where there was at least 5% of blinded or not blinded out
of the total number of mammograms read at the centre
(Supplementary Material Appendix C).
Interval cancers within 3 years of screening were used to
estimate test accuracymetrics for blinded/non-blinded reading
(sensitivity, specificity, PPV, negative predictive value
(NPV)). We separated the women not recalled into ‘false neg-
atives’ (women not recalled who had an interval cancer within
3 years of screening) and ‘true negatives’ (women not recalled
and either did not have an interval cancer recorded in their
follow-up data or did not have follow-up data). For consisten-
cy within this analysis, anyone recalled, had no cancer detect-
ed, and had an interval cancer within 3 years of screen was
classified as a true positive, rather than a false positive. We
performed an equality of proportions test to determine wheth-




A total of 1,119,191 women were included from 43 screening
centres with 9656 cancers detected after arbitration (0.86%).
The mean age of the women was 59, and 78.8% had previ-
ously attended screening (881,900/1,119,191). The study flow
diagram is depicted in Fig. 1. Study characteristics and out-
comes by blinding status are presented in Table 1. Of the 43
centres, 23 centres were classified as not blinded, 14 as
blinded, and 6 as mixed. There were 418 first readers and
420 second readers. Reader 2 was blinded for 34.2% of wom-
en screened.
Alliterative bias
Rates of disagreement between the two readers for recall were
0.20% points higher when blinded (3.57%; 95% CI: 3.51%,
3.63%) than when not (3.37%; 95% CI: 3.33%, 3.41%) (χ2(1)
= 32.46, p < 0.001). The disagreement rate difference in-
creases to 5.60% points when the first reader recalls the case
(38.61%; 95% CI: 37.92%, 39.29%) when reader 2 is blinded
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versus (33.01%; 95% CI: 32.55%, 33.48%) when reader 2 is
not blinded (χ2(1) = 179.03, p < 0.001) (Supplementary
Table B.2).
The multilevel model results show a similar pattern (Fig.
2). When reader 1 recalls, the probability of reader 2 recalling
is 4.9% points lower when blinded (69.8%; 95% credible
interval: 67.9%, 71.5%) versus not blinded (74.7%; 95% cred-
ible interval: 73.2%, 76.1%) for a woman’s first screen. If
reader 1 does not recall, the probability of reader 2 recalling
when blinded (2.33%; 95% credible interval: 2.14, 2.53%)
and not blinded (2.32%; 95% credible interval: 2.15, 2.50%)
is similar for a woman’s first screen. The model and full prob-
abilities are reported in Supplementary Tables B.1 and B.3.
Recall rate, cancer detection rate, and PPV
Recall rate
Reader 2 (before arbitration) recalled 0.45% points fewer
women when blinded (4.73%; 95% CI: 4.67%, 4.80%) than
when not blinded (5.18%; 95% CI: 5.13%, 5.23%) (χ2(1) =
107.04, p < 0.001). However, reader 1 (who cannot see reader
2’s decision, as by definition it does not yet exist) also recalled
fewer women (0.26% points) when reader 2 was blinded
(5.09%; 95% CI: 5.02%, 5.16%) than when not blinded
(5.35%; 95% CI: 5.30%, 5.40%) (χ2(1) = 34.751, p < 0.001)
indicating at least part of this effect may be due to confound-
ing (Table 1).
Recall rate after arbitration was lower when reader 2 was
blinded (3.96%; 95% CI: 3.90%, 4.02%) compared to when
they were not (4.16%; 95%CI: 3.93%, 4.38%) (χ2(1) = 24.51,
p < 0.001). A model assessing the effect of blinding reader 2
on the recall rate after arbitration is presented in Table 2 and
Fig. 3. Blinding reader 2 decreased the odds of recall from
screening compared to not blinding (OR 0.869; 95% credible
interval 0.826, 0.913) for a woman of average age (59 years)
who has previously been screened (Table 2).
The interactions for the recall rate model were dissected in
an interaction plot (Fig. 3). Blinding reader 2 decreased the
odds of recall after arbitration for both first time and subse-
quent screens, and for all ages. The trend was towards a great-
er effect of blinding on recall rate at younger ages, and when
the woman had previously attended screening. For both first
and subsequent screen mammograms of 60-year-old women,
women were less likely to be recalled if reader 2 was blinded
than if they were not: first screen OR 0.923 (95% credible
interval 0.864, 0.986), subsequent screen OR 0.871 (95%
credible interval 0.829, 0.915) (Fig. 2, Table A.2
Supplementary Material).
Analysis of the subset of 179,573 women at the six centres
in which there was a mixture of blinded/unblinded second
readers showed similar results. Blinding the second reader
Fig. 1 Study flow diagram with
reasons for exclusions. There
were 46 centres in the CO-OPS
trial, but three shared a common
computer system so are counted
as one centre in this analysis, a
further centre was removed which
had no reader identifiers, giving
43 centres in the dataset. Of the 43
centres, 23 centres were classified
as not blinded, 14 as blinded, and
6 as mixed. Reader 2 was blinded
for 34.2% (382,490/1,119,191) of
women screened
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was associated with a lower recall rate after arbitration than
when the second reader was not blinded (OR 0.883; 95%
credible interval 0.834, 0.933) (Supplementary Table C.2).
Cancer detection rate
Reader 2 (before arbitration) detected cancers in 0.84% (95%
CI: 0.81%, 0.87%) of women when blinded versus 0.83%
(95% CI: 0.81%, 0.85%) when not blinded (χ2(1) = 0.51,
p = 0.48). The cancer detection rate overall (with arbitration)
was similar when reader 2 was blinded (0.88%; 95% CI:
0.85%, 0.91%) compared to when not (0.86%; 95% CI:
0.83%, 0.88%, χ2(1) = 1.4, p = 0.2).
The model determining the association of blinding with
cancer detection rate after arbitration is reported in Table 3.
The association between blinding and cancer detection was
not statistically significant (OR 1.029; 95% credible inter-
val: 0.970, 1.089; p = 0.341), although the Bayesian p val-
ue suggests that 83.2% of estimates lie above an odds ratio
of 1 (showing a potent ia l pos i t ive associa t ion)
(Supplementary Material Table A.5). Cancer detection also
increases with age and with a first screen versus a subse-
quent screen.
Analysis of the subset of six centres (179,573 women)
where there is a mix of blinded/unblinded second readers
showed similar results (Supplementary Table C.4).
Tumour characteristics
Tumour characteristics by whether reader 2 is blinded or
not is shown in Supplementary Table D.1. Invasive disease
was present in 78.4% (2570/3277) for blinded and 76.6%
(4503/5881) for not blinded (χ2(1) = 4.0, p = 0.0449); with
no significant evidence of any difference for disease grade
(χ2(2) = 0.67, p = 0.7), the number of positive axillary
nodes (χ2(2) = 3.0, p = 0.2), and the mean diameter of the
tumour for blinded (16.5 mm, standard deviation (SD) 12.6
mm) and not blinded (16.2 mm, SD 11.8 mm; t = 1.0, p =
0.3). When invasive disease was not present, there was no
evidence of an effect of blinding on grade of DCIS
(χ2(2) = 1.99, p = 0.37).
Table 1 Characteristics of the
study sample, and recall and
cancer detection rates for blinded
versus not blinded reader 2





Age of woman (mean) Mean age 59.2 - 59.3 -
Group 1 (52 or less) 90,505 23.66 167,217 22.70
Group 2 (53-59) 111,642 29.19 214,996 29.18
Group 3 (60 or more) 180,343 47.15 354,488 48.12
Total 382,490 100.00 736,701 100.00
First screen/subsequent screen Subsequent screen 300,820 78.65 581,080 78.88
First screen 81,670 21.35 155,621 21.12
Total 382,490 100.00 736,701 100.00
Reader 1
Recall (pre arbitration)
Not recalled 363,034 94.91 697,294 94.65
Recalled 19,456 5.09 39,407 5.35
Total 382,490 100.00 736,701 100.00
Reader 2
Recall (pre arbitration)
Not recalled 364,387 95.27 698,512 94.82
Recalled 18,103 4.73 38,189 5.18
Total 382,490 100.00 736,701 100.00
Recall (after arbitration) Not recalled 367,341 96.04 706,082 95.84
Recalled 15,149 3.96 30,619 4.16
Total 382,490 100.00 736,701 100.00
Cancers detected by reader 1 Cancer detected 3066 0.80 5717 0.78
No Cancer detected 379,424 99.20 730,984 99.22
Total 382,490 100.00 736,701 100.00
Cancers detected by reader 2 Cancer detected 3226 0.84 6117 0.83
No cancer detected 379,264 99.16 730,584 99.17
Total 382,490 100.00 736,701 100.00
Cancers detected overall
(after arbitration)
Cancer detected 3355 0.88 6301 0.86
No Cancer detected 379,135 99.12 730,400 99.14
Total 382,490 100.00 736,701 100.00
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Fig. 2 Facet plot showing the probability (with 95% credible interval) of
reader 2 recalling a woman (at the mean age of 59.27) bywhether reader 1
(R1) recalls or not, when reader 2 (R2) is blinded and not blinded. Results
also presented for women who are first time screens or subsequent
screens. The probability of recall is lower for a woman attending a sub-
sequent screen compared to attending a first-time screen
Table 2 Markov chain Monte
Carlo (MCMC) multilevel model
determining the effect of blinding
on recall rate overall (after arbi-
tration). The full model including
one-sided Bayesian p values is
reported in the Supplementary
Material (Table A.1) along with
the caterpillar plot showing level
3 residuals and their 95% CIs
(Figure A.1)
Recall rate overall (after arbitration) multilevel model
Fixed Effects Odds ratioa 95% credible interval
for the odds ratiob
Pr(>|z|)c
Blinding Yes (versus no as the reference category) 0.869 0.826, 0.913 < 0.001
Age (centred) 1.007 1.005, 1.009 < 0.001
First screen (versus subsequent screen as the
reference category)
2.823 2.728, 2.922 < 0.001
Blinded yes * age (interaction term) 1.005 1.001, 1.008 0.015
Blinding yes * first screen (interaction term) 1.060 0.999, 1.125 0.057
aThe mean of the 100,000 chain iterations after converting from the log odds scale to the odds scale.
b 95% credible interval is generated by taking the 2.5th and 97.5th quantiles of the 100,000 chain iterations after
converting from the log odds scale to the odds scale




The PPV after arbitration was 22.1% (3355/15,149; 95% CI:
21.5%, 22.8%) for blinded and 20.6% (6301/30,619; 95% CI:
20.1%, 21.0%) when not blinded (χ2(1) = 14.9, p < 0.001)
(Table 4).
Further test accuracy estimates based on interval cancer data
Interval cancers within 3 years of screening were used to
estimate test accuracy metrics and are shown in Table 5.
The estimated sensitivity was 82.44% (3399/4123; 95% CI:
81.28%, 83.60%) for blinded and 82.60% (6391/7737; 95%
CI: 81.76%, 83.45%) for not blinded (χ2(1) = 0.04, p =
0.84). The difference for specificity was statistically signif-
icant: 96.89% for blinded and 96.68% for not blinded
(χ2(1) = 37.6, p < 0.001).
Discussion
Summary of results
We examined the effect that blinding reader 2 to the decision of
reader 1 had on behaviour and outcomes using data from the
English Breast Cancer Screening Programme. When reader 1
Fig. 3 Interaction plot displaying
the odds ratios (median and 95%
credible intervals) of recall rate
after arbitration when reader 2 is
blinded versus not blinded by
screen status and age. See
accompanying Table A.2 in the
Supplementary Material
Table 3 Markov chain Monte Carlo (MCMC) multilevel model deter-
mining the effect of blinding on cancers detected overall (after arbitra-
tion). Interactions were not included for this model due to both a higher
deviance information criterion (DIC) in comparison to a model without
and non-significant p values for the estimates. The full model including
one-sided Bayesian p values is reported in the Supplementary Material
(Table A.5) along with the caterpillar plot showing level 3 residuals and
their 95% CIs (Figure A.3)
Cancer detection overall (after arbitration) multilevel model
Fixed effects Odds ratioa 95% credible interval for the odds ratiob Pr(>|z|)c
Blinding yes (versus no as the reference category) 1.029 0.970, 1.089 0.341
Age (centred) 1.052 1.049, 1.056 < 0.001
First screen (versus subsequent screen as the reference category) 1.696 1.591, 1.807 < 0.001
aThe mean of the 100,000 chain iterations after converting from the log odds scale to the odds scale
b 95% credible interval is generated by taking the 2.5th and 97.5th quantiles of the 100,000 chain iterations after converting from the log odds scale to the
odds scale
cTwo-tailed p value of the z score for the coefficient (testing whether the estimate is significantly different from 0 assuming normality)
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recalled, the probability of reader 2 recalling was around 5%
points lower when blinded versus not (69.8% vs 74.7%), sug-
gesting that without blinding they are influenced by the decision
of reader 1 and alliterative bias is present. This has the potential
to increase recall rates by bypassing arbitration in systems where
there is arbitration of discordant decisions. We found that the
overall odds of recalling women for further tests were lower
and specificity was higher when reader 2 was blinded to the
decision of reader 1 compared to when not blinded. Similarly,
the PPV after arbitration when reader 2 was blinded was slightly
higher (22.1%) versus when not (20.6%, p < 0.001). We also
found a difference (albeit smaller) in reader 1 recall rates when
reader 2 was blinded versus unblinded. This may be due to
reader 1 changing their behaviour in anticipation of reader 2
viewing their decision, a training effect from independent read-
ing, or it may be an indication of centre level confounding.
Comparison with the literature
We identified only one study that directly statistically com-
pared the effects of blinding reader 2 compared to not blinding
reader 2 in the setting of a breast cancer screening programme
[11]. This study used a system of recalling all discordant re-
sults. Klompenhouwer et al [11] found that when reader 2 was
not informed of the decision of reader 1, the sensitivity of the
screening programme was higher (83.1% vs 75.5%), recall
rate was higher (3.3% vs 2.9%), false positive referrals were
higher (2.6% vs 2.2%), and the interval cancer rate was lower
(1.5 per 1000 screens vs 2.1 per 1000 screens). There was no
difference in PPV, cancer detection rate, or proportion of BI-
RADS 4 or 5. This provides some evidence of the impact of
blinding, but is not applicable to screening programmes where
discordant decisions are arbitrated.
Table 4 Two by two table of
positive predictive value (PPV)
for both after arbitration and for
reader 2 against whether reader 2
is blinded or not. Chi-squared test
for independence assesses wheth-
er PPV after arbitration is inde-
pendent of blinding (χ2(1) = 14.9,
p < 0.001) and whether PPV of
reader 2 is independent of






Cancer detected (TP) after arbitration 3355 6301 9656
Recall (after arbitration), no cancer detected (FP) 11,794 24,318 36,112
Total recalled (TP + FP) 15,149 30,619 45,768
PPV (TP/total recalled) % 22.1% 20.6% -
Cancer detected (TP) (reader 2) 3226 6117 9343
Recall (reader 2), no cancer detected (FP) 14,877 32,072 46,949
Total recalled (TP + FP) 18,103 38,189 56,292
PPV (TP/total recalled)% 17.8% 16.0% -
Table 5 Test accuracy statistic estimates for reader 2 blinded or not blinded. Cancer includes those detected at the screen and interval cancers within 3








Detected Interval None Total Detected Interval None Total
Recall (after arbitration) Yes 3355 44 11,750 15,149 6301 90 24,228 30,619 -
No 0 724 366,617 367,341 0 1346 704,736 706,082 -
Total 3355 768 378,367 382,490 6301 1436 728,964 736,701 -
Test accuracy statistics 95% confidence interval 95% confidence interval χ2(1) p
Sensitivity 82.44% (81.28%,83.60%) 82.60% (81.76%,83.45%) 0.0390 0.843
Specificity 96.89% (96.84%,96.95%) 96.68% (96.64%,96.72%) 37.6 < 0.001
PPV 22.44% (21.77%,23.10%) 20.87% (20.42%,21.33%) 14.7 < 0.001
NPV 99.80% (99.79%,99.82%) 99.81% (99.80%,99.82%) 0.491 0.483
PPV positive predictive value, NPV negative predictive value
Number of women with cancer used in the “test accuracy” statistics found by adding the detected and interval cancers together
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Follow on studies assessed the impact of arbitration ver-
sus no arbitration of discrepant readings for both blinded
and non-blinded reading [13, 14]. To do this, they random-
ly assigned a third reader to decide retrospectively whether
to recall a discrepant reading [13]. Although blinded dou-
ble reading with arbitration was not directly statistically
compared to non-blinded double reading with arbitration,
the recall rate was lower for blinded reading 2.2% versus
2.3% for non-blinded reading, PPV was higher 31.2%
compared to 27.5%, and cancer detection rate was 6.8 per
1000 screens versus 6.3 per 1000 screens with the propor-
tion of BI-RADS 0 (low suspicion lesions) among recalls
at 23.0% versus 26.7%. Sensitivity was 76% for blinded
versus 72.7%. Our results show this effect of increased
PPV and decreased recall rate with blinding is present also
in clinical practice, and is statistically significant. Both
studies are inconclusive on the effect of blinding on cancer
detection and sensitivity, with trends towards increases
which are not statistically significant.
In summary, the previous studies in the Dutch screening
programme have shown that when all discordant decisions are
recalled, blinding increases cancers detected at screening, and
number of false positive recalls to assessment, but with similar
PPV. They projected that in screening programmes with arbi-
tration blinding may increase PPV; this was a retrospective
analysis rather than prospective measurement. Our study find-
ings aligns with these and expands them. In clinical practice
where arbitration is used, our study suggests that blinding
improves PPV through increases to specificity. We also found
evidence of alliterative bias, which explains the mechanism of
action of these effects.
Strengths and limitations
This study has a number of key strengths. For example, we
used a large dataset that was collected as part of a breast
screening programme, which included a representative sample
of screening centres and women in England, and had very
little missing data. We also used a Bayesian approach to
modelling, fitting models with MCMC methods. These
methods generate a sample from the posterior probability dis-
tribution of the parameter which can then be summarised by
giving the probability of the coefficient being greater/smaller
than 0. This enabled us to assess whether the evidence was
compelling enough that the cancer detection rate may increase
when the second reader is blinded. Overreliance on the use of
a statistically significant cut-off level under frequentist infer-
ence may lead to the dismissal of clinically relevant effects
[26–28]. Our research provided Bayesian p values as an addi-
tional measure which can convey the strength of the blinding
effect.
The study has limitations. Our data are observational, so
we cannot conclude that blinding is causing the
improvement in PPV and reduction in recall. Reader 2
was also shown to perform better than reader 1 under both
blinded and non-blinded conditions, suggesting that poten-
tially more experienced and senior readers read second
more frequently. To reduce this potential bias, trainee
readers were removed from the population sample. In this
study, we measured readers’ decisions and the woman’s
outcomes, but no measurements were made of reading be-
haviour or how the second reader may have used the first
reader’s decision. The blinded versus non-blinded im-
provement is also seen to a lesser extent in reader 1 which
cannot be caused by the alliterative effect. Services that
used blinding could have more experienced readers overall
or could serve a different population demographic of
screened women (e.g. by ethnicity, socioeconomic status).
Differences between centres were however addressed by
clustering by centre and reader as well as controlling by
age and screening status. Finally, our 5% rule for designat-
ing a centre as blinded/not blinded/mixed was arbitrarily
selected.
Policy implications
In breast screening programmes with arbitration of discordant
decisions between readers, blinding the second reader to the
decision of the first may improve the PPV of breast cancer
screening and reduce the number of women recalled for further
testing. The results suggest that reader 2 might be influenced
by, and conform to, reader 1’s decisions when not blinded,
particularly if a woman has been recalled by reader 1 (potential
alliterative bias). Sowhen reader 2 is not blinded, they appear to
be copying some of the recall decisions of reader 1, and there-
fore bypassing the arbitration process and increasing recall rates
and false positives. A previous study (where the arbitration was
in a laboratory rather than screening practice context) predicted
similar patterns [13, 14]. The effect on cancer detection rate is
unclear, but the point estimates were higher when blinded in
both studies. These results are not generalizable to screening
programmes where all discordant decisions are recalled. In that
context, previous research has suggested blinding increases
cancer detection and false positive recall, whilst maintaining
similar PPV.
Conclusions
Our results suggest that when not blinded reader 2 is influ-
enced by reader 1’s decisions to recall (alliterative bias) which
would result in bypassing arbitration and negate some of the
benefits of double reading. We found a relationship between
blinding the second reader and slightly higher PPV of breast
cancer screening, although this analysis may be confounded
by other centre characteristics. We would recommend blinded
Eur Radiol
over non-blinded double reading in centres that use arbitration
of discordant decisions.
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